Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | -2.12% | -5.61% | -13.15% |
05-08 | Erasca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-03 | North American Morning Briefing : Powell Awaited -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.15% | 320M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+49.11% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- ERAS Stock
- News Erasca, Inc.
- Erasca Doses First Patient in Trial Assessing Naporafenib Plus Trametinib in Patients With RAS Q61X Solid Tumors